A rare disease drug that Sanofi added via its $11.6 billion Bioverativ acquisition is now approved for treating the blood disorder cold agglutinin disease. The regulatory nod makes the antibody ...

Use discretion or consult a local health professional. Common symptoms of cold agglutinin disease include: Dizziness Fatigue Irritability Headaches Cold hands and feet which may be associated with ...

Discover how BioCryst Pharmaceuticals' patent for complement system inhibitors offers groundbreaking treatment options for various diseases.

Your Artstor image groups were copied to Workspace. The Artstor website will be retired on Aug 1st. The Journal of Infectious Diseases Vol. 41, No. 1, Jul., 1927 Precipitin, Lysin and Agglutinin Tests ...

In a note to clients, the analysts at Mizuho cut the firm's price target for the stock to $52 from $60 per share, saying they have updated their model. APLS's stock is currently trading at $43.87, ...

Annexon (ANNX) is expected to provide updates from the phase III study evaluating its lead candidate, ANX005, for the treatment of GBS in the first-quarter earnings release.